Home
Live Updates
Takeda Pharmaceutical : Submits New Drug Application for Novavax COVID-19 Vaccine Candidate in Japan : comparemela.com
Takeda Pharmaceutical : Submits New Drug Application for Novavax' COVID-19 Vaccine Candidate in Japan
News Release
Takeda Submits New Drug Application for Novavax' COVID-19 Vaccine Candidate
in Japan
... | December 16, 2021
Related Keywords
Japan ,
Mexico ,
Osaka ,
United States ,
Japanese ,
Novavaxand Moderna ,
Biologika Gmb ,
Masayuki Imagawa ,
Amy Atwood ,
Plasma Alliance ,
Takeda Pharmaceutical Company Limited ,
Ministry Of Health ,
Innovative Medicines Initiative ,
Takeda Pharmaceutical Company ,
Exchange Commission ,
Covid Rd Alliance ,
Companies Of Johnson ,
Government Of Japan Ministry Health Labour ,
Devices Agency ,
Japan Agency For Medical Research ,
Japan Pharmaceuticals ,
World Health Organization Vaccines ,
News Release ,
Submits New Drug Application ,
Ongoing Phase ,
Safety Clinical Trial ,
Efficacy Data ,
Novavax Two Pivotal Phase ,
Pharmaceutical Company Limited ,
New Drug Application ,
Both Phase ,
Medical Devices Agency ,
Japan Vaccine Business Unit ,
Japan Agency ,
Medical Research ,
Health Labour ,
Pharmaceutical Companies ,
Rare Genetics ,
Plasma Derived Therapies ,
Outside Japan Amy Atwood ,
Annual Report ,
Health Organization Vaccines ,
Retrieved December ,
Takeda Pharmaceutical Company Limited Stock Exchange ,
News ,
Information ,
Press Release ,
Makeda ,
Ubmits ,
Few ,
Drug ,
Application ,
Or ,
Vaccine ,
N 4502 Jp3463000004 ,
comparemela.com © 2020. All Rights Reserved.